Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Hashimoto, T. Articles by Lewis, D. A. Search for Related Content PubMed Citation Articles by Hashimoto, T. Articles by Lewis, D. A. Schizophrenia Spectrum Disorders Genetics

BDNF Val66Met Polymorphism and GAD₆₇ mRNA Expression in the Prefrontal Cortex of Subjects With Schizophrenia

OBJECTIVE: In the prefrontal cortex of subjects with schizophrenia, decreased signaling mediated by brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase (TrkB) appears to contribute to the reduced expression of mRNA encoding the 67-kilodalton isoform of glutamate decarboxylase (GAD₆₇), an enzyme for GABA synthesis. The authors examined in subjects with schizophrenia the effect in the human BDNF gene of a single nucleotide polymorphism (Val66Met), which reduces the trafficking and secretion of BDNF protein, on the expression of GAD₆₇ mRNA. METHOD: BDNF Val66Met genotyping was performed in 27 matched pairs of schizophrenia and comparison subjects. The impact of this polymorphism on prefrontal cortex GAD₆₇ mRNA expression in schizophrenia subjects was assessed by comparing within-pair differences in GAD₆₇ mRNA expression between schizophrenia subjects with versus without the Met66 allele after the level of BDNF mRNA expression was controlled. RESULTS: In contrast to expectations, the within-pair reduction in GAD₆₇ mRNA expression was not greater in schizophrenia subjects who were hetero- or homozygous for the Met66 allele. These subjects did tend to exhibit less marked within-pair reductions in both GAD₆₇ and BDNF mRNA expression compared with schizophrenia subjects homozygous for the Val allele. CONCLUSIONS: The presence of the BDNF Met66 allele does not contribute to the decreased level of GAD₆₇ mRNA expression in the prefrontal cortex of subjects with schizophrenia.

This article has been cited by other articles:

				H.-A. Chang, R.-B. Lu, M.-J. Shy, C.-C. Chang, M.-S. Lee, and S.-Y. Huang Brain-Derived Neurotrophic Factor Val66Met Polymorphism: Association With Psychopathological Symptoms of Schizophrenia? J Neuropsychiatry Clin Neurosci, February 1, 2009; 21(1): 30 - 37. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us